Depreciation of MoonLake Immunotherapeutics from 31 Mar 2022 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: MoonLake Immunotherapeutics quarterly and annual Depreciation in USD history and change rate from 31 Mar 2022 to 31 Mar 2024.
MoonLake Immunotherapeutics Depreciation for the quarter ending 31 Mar 2024 was $22,813, a 593% increase year-over-year.
MoonLake Immunotherapeutics annual Depreciation for 2023 was $13,158, a 6.5% increase from 2022.
Source SEC data: View on sec.gov

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Change (%)

Depreciation, Annual (USD)

Depreciation, YoY Annual Change (%)

MoonLake Immunotherapeutics Quarterly Depreciation (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$22,813	+$19,523	+593%	01 Jan 2024	31 Mar 2024	10-Q	07 May 2024	2024	Q1
Q1 2023	$3,290	+$802	+32%	01 Jan 2023	31 Mar 2023	10-Q	07 May 2024	2024	Q1
Q1 2022	$2,488			01 Jan 2022	31 Mar 2022	10-Q	11 May 2023	2023	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2023	$13,158	+$800	+6.5%	01 Jan 2023	31 Dec 2023	10-K	29 Feb 2024	2023	FY
2022	$12,358			01 Jan 2022	31 Dec 2022	10-K	29 Feb 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.